Chemical formula: C₃₈H₅₀N₆O₅ Molecular mass: 670.841 g/mol PubChem compound: 441243
Saquinavir selectively inhibits the HIV protease, thereby preventing the creation of mature infectious virus particles. The HIV protease is an essential viral enzyme required for the specific cleavage of viral gag and gag-pol polyproteins.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J05AE01 | Saquinavir | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| INVIRASE Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Saquinavir is an active ingredient of these brands:
United States (US)
Australia (AU)
Austria (AT)
Cyprus (CY)
Estonia (EE)
Hong Kong (HK)
Ireland (IE)
Lithuania (LT)
Netherlands (NL)
Poland (PL)
South Africa (ZA)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
